About Nerve Trace Inc.
Connected diagnostics.
Nerve Trace is redefining how nerve fiber biopsies are analyzed — uniting AI precision, clinical workflows, and interoperable data standards. Our mission is to modernize peripheral neuropathy diagnostics through automation, transparency, and reproducibility.
Mission Statement
To accelerate nerve health research and diagnostics with transparent, AI-powered analysis.
Our Story
From manual counting to intelligent analysis.
Our founding story.
We founded Nerve Trace after years working at WinSanTor, a leader in regenerative-nerve therapeutics advancing Phase 3 treatments for peripheral neuropathy. While supporting clinical trials, we managed in-house ENFD and IENFD pathology programs and saw firsthand how manual nerve-fiber quantification limited scalability, speed, and consistency. Even with expert pathologists, variability in tracing and reporting slowed trial timelines and increased cost per case.
Nerve Trace was created to solve that bottleneck. Our AI analysis layer automates epidermal and intraepidermal nerve-fiber detection, quantification, and reporting with validated precision—reducing turnaround time, standardizing outputs, and enabling consistent data across labs and studies. Today, we partner with clinical sites, CROs, and diagnostic labs to make nerve-fiber density testing faster, reproducible, and globally accessible.
Common Queries
Frequently Asked Questions
Get the answers you need. Browse our FAQs for more information about Nerve Trace Inc.
